Evidence map›Paper›PMID 42551489›Full record

ArticleBrain pathology (Zurich, Switzerland)2026

Brain metastasis-associated fibroblasts shape the tumour microenvironment to enhance cancer cell invasion.

Barbora Výmolová, Lucie Pfeiferová, Tadeáš Karel Smetana, Petr Výmola, Nikola Ternerová, Michal Zubaľ, Michal Kolář, Jana Šáchová, Soňa Gyönyörová, Eva Balážiová and 10 more

Abstract read
In one paragraph

Article in Brain pathology (Zurich, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Barbora VýmolováLaboratory of Cancer Cell Biology, Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, Prague 2, Czech Republic.ORCID https://orcid.org/0000-0002-6100-1125
Lucie PfeiferováLaboratory of Genomics and Bioinformatics, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague 4, Czech Republic.
Tadeáš Karel SmetanaLaboratory of Cancer Cell Biology, Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, Prague 2, Czech Republic.ORCID https://orcid.org/0009-0006-5419-0665
Petr VýmolaLaboratory of Cancer Cell Biology, Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, Prague 2, Czech Republic.
Nikola TernerováLaboratory of Cancer Cell Biology, Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, Prague 2, Czech Republic.ORCID https://orcid.org/0009-0000-7825-3735
Michal ZubaľLaboratory of Cancer Cell Biology, Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, Prague 2, Czech Republic.ORCID https://orcid.org/0000-0001-6556-6185
Michal KolářLaboratory of Genomics and Bioinformatics, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague 4, Czech Republic.ORCID https://orcid.org/0000-0002-4593-1525
Jana ŠáchováLaboratory of Genomics and Bioinformatics, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague 4, Czech Republic.ORCID https://orcid.org/0000-0003-1176-6127
Soňa GyönyörováLaboratory of Cancer Cell Biology, Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, Prague 2, Czech Republic.
Eva BalážiováLaboratory of Cancer Cell Biology, Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, Prague 2, Czech Republic.
Magdalena Houdová MegováLaboratory of Cancer Cell Biology, Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, Prague 2, Czech Republic.
Jakub ČervenkaLaboratory of Proteomics, Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, Prague 2, Czech Republic.ORCID https://orcid.org/0000-0002-9947-2045
Helena Kupcová SkalníkováLaboratory of Proteomics, Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, Prague 2, Czech Republic.ORCID https://orcid.org/0000-0003-0591-5018
Michal ŠpankoInstitute of Anatomy, First Faculty of Medicine, Charles University, Prague 2, Czech Republic.
Karel SmetanaInstitute of Anatomy, First Faculty of Medicine, Charles University, Prague 2, Czech Republic.ORCID https://orcid.org/0000-0002-7878-8403
Lukáš LacinaInstitute of Anatomy, First Faculty of Medicine, Charles University, Prague 2, Czech Republic.ORCID https://orcid.org/0000-0002-1750-9933
David NetukaDepartment of Neurosurgery and Neurooncology, First Faculty of Medicine, Charles University and Military University Hospital, Prague 6, Czech Republic.
Robert TomášDepartment of Neurosurgery, Motol and Homolka University Hospital, Prague 5, Czech Republic.
Petr BušekLaboratory of Cancer Cell Biology, Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, Prague 2, Czech Republic.ORCID https://orcid.org/0000-0003-2158-4837
Aleksi ŠedoLaboratory of Cancer Cell Biology, Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, Prague 2, Czech Republic.ORCID https://orcid.org/0000-0002-3247-5436

Funding

Ministerstvo Školství, Mládeže a Tělovýchovy České Republiky EATRIS-CZ LM2023053Ministerstvo Zdravotnictví České Republiky NU22-03-00318Operational Program Research, Development and EducationProgramme EXCELES LX22NPO5102Project 'Center of Tumor Ecology' CZ.02.1.01/0.0/0.0/16_019/0000785Univerzita Karlova v Praze, Cooperatio, research area "Oncology and Haematology GAUK 342522
6 · The paper itself

Abstract

Brain metastases (BrM) are a frequent and life-threatening complication of solid tumours, with lung cancer representing their most common source. While cancer-associated fibroblasts (CAFs) are well-established contributors to tumour progression in many extracranial malignancies, their presence and function within the brain tumour microenvironment, where fibroblasts have long been considered scarce or absent, remain poorly understood. Here, we isolated and characterised fibroblast-like cells from 13 human BrMs of diverse origins. These BrM-associated CAFs (BrM-CAFs) expressed canonical CAF markers and showed reduced proliferation and increased senescence compared to normal fibroblasts. Their transcriptome was enriched for extracellular matrix (ECM)-related genes, including multiple collagens, fibronectin, and matrix-remodelling enzymes. In vitro, BrM-CAFs produced a fibrillar ECM, and in BrM tissues, their abundance was associated with collagen I and fibronectin deposition. Transcriptomic, proteomic, and secretome analyses further revealed that BrM-CAFs produce multiple cytokines, chemokines, and growth factors that promote cell motility. BrM-CAF conditioned medium promoted both monocyte migration and the migration of cancer cells, including established cell lines and patient-derived lung cancer BrM cells; monocyte migration was partially reduced by inhibition of CCL2/CCR2 signalling, whereas blocking CXCL12, CXCL16, or CX3CL1 attenuated BrM-CAF-induced cancer cell migration. Beyond these effects on migration, exposure to BrM-CAFs increased cancer cell invasion in transwell and heterotypic 3D spheroid assays. In contrast, their effects on cancer cell proliferation were limited and did not indicate a growth-promoting role. Exposure to BrM-CAFs was also associated with increased expression of interferon-stimulated genes in cancer cells. Together, our findings support a role for BrM-CAFs in shaping the brain metastatic microenvironment through ECM remodelling and the secretion of pro-migratory mediators, promoting monocyte and cancer cell migration and enhancing cancer cell invasion. These data identify BrM-CAFs as active stromal participants in BrM biology and support further investigation of their biological, diagnostic, and therapeutic relevance.

Indexed as

brain metastasescancer‐associated fibroblastscell migrationextracellular matrixprimary cell culturetranscriptome

Identifiers

PMID42551489
PMCPMC13437050

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.